Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases

Abdul Mannan Khan Minhas1, Khawaja M Talha1, Dmitry Abramov2

  • 1Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

Insights

Racial disparities in cardiovascular disease (CVD) are widespread. Non-Hispanic Black adults face significant disadvantages in CVD prevalence, risk factors, mortality, and treatment compared to Non-Hispanic White adults.

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Health Disparities Research

Background:

  • Existing studies analyze cardiovascular disease (CVD) disparities using various databases, but a unified analysis is lacking.
  • This study addresses the need for a comprehensive examination of racial and ethnic disparities in CVD within the US.

Purpose of the Study:

  • To examine racial and ethnic disparities in CVD prevalence, risk factors, morbidity, and mortality.
  • To assess disparities in cardiovascular trainee representation across racial and ethnic groups.

Main Methods:

  • Utilized multiple large-scale datasets: National Health and Nutrition Examination Survey, National Ambulatory Medical Care Survey, National Inpatient Sample, CDC WONDER, UNOS, and ACGME.
  • Evaluated disparities among Non-Hispanic (NH) White, NH Black, and Hispanic populations.

Main Results:

  • NH Black adults exhibited higher prevalence of most CVDs and risk factors, except dyslipidemia and ischemic heart disease (IHD).
  • Underutilization of statins for IHD in NH Black and Hispanic patients was observed. Hospitalizations for heart failure (HF) and stroke were higher in NH Black patients.
  • NH Black individuals experienced the highest mortality rates for all-cause, CVD, HF, acute myocardial infarction, IHD, diabetes mellitus, hypertension, and cerebrovascular disease. Representation of NH Black and Hispanic trainees in CVD fellowship programs was disproportionately low.

Conclusions:

  • Racial disparities are pervasive across the entire spectrum of cardiovascular diseases.
  • Non-Hispanic Black adults are at a significant disadvantage compared to Non-Hispanic White adults regarding most CVD outcomes and representation in training.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
366
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186